Latest SeraCare Stories
MILFORD, Mass., May 2, 2011 /PRNewswire/ -- SeraCare Life Sciences announced today that the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has awarded a new contract to SeraCare, replacing the current contract which expired on April 30, 2011.
SeraCare Life Sciences, Inc. (NASDAQ: SRLS) launched the Company's anticipated genetic controls business with the introduction of two new products at the Association for Molecular Pathology 2008 Annual Meeting.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.